[October 22, 2016] |
|
Boosting Productivity in Blood Banking and Cellular Processing Applications
AABB 2016 - Blood processing and cellular therapy
laboratories can now benefit from equipment designed to deliver
accelerated throughput and optimal sample safety in a sustainable manner.
Blood banking and cellular therapy centers function as production
facilities. As such, high-throughput capabilities that enable run-to-run
reproducibility while maintaining sample integrity and process control
are essential to ensuring continuous, uninterrupted operation. With
refrigerators, freezers and centrifuges playing a key role in the blood
processing workflow, the latest storage and separation equipment has
been developed to accommodate the need for improved round-the-clock
productivity and ergonomic workflow, all while minimizing environmental
impact and adhering to global standards.
"Common challenges facing blood processing and cellular therapy
facilities include working with large volumes of blood products or
timely processing of critical, sensitive samples and there is increasing
pressure to deliver accurate results more quickly to facilitate medical
research and patient well-being," said Bill McMahon, president,
laboratory equipment, Thermo Fisher Scientific. "With this in mind, we
are focusing product development within these sectors on
well-established technologies that are designed for simplified and safe
blood processing and cell therapy applications, while boosting
productivity in an easy-to-use, ergonomic manner."
The latest technological advancements from Thermo Fisher are being
showcased at the annual American Association of Blood Banks (AABB)
conference, Booth 1627, at the Orange (News - Alert) County Convention Center in
Orlando, Florida, including the Thermo Scientific TSX Series of
high-performance blood bank refrigerators and high-performance plasma
freezers, the Thermo Scientific Sorvall BP 8 and 16 blood banking
centrifuges, and the Thermo Scientific Medifuge benchtop centrifuge.
-
The new Thermo Scientific TSX Series of high-performance blood bank
refrigerators operate at a factory pre-set temperature of 4°C to
comply with the AABB guidelines for the storage of whole blood and
blood components. Thermo Scientific TSX Series of high-performance
plasma freezers have also been developed to meet the guidelines
established by the AABB for the storageof plasma. Like the previously
introduced TSX Series of ultra-low freezers, the TSX Series
high-performance refrigerators and freezers are powered by the unique
V-Drive technology, designed to deliver improved performance and
significant energy savings. The V-Drive, combined with superior
insulation, also ensures up to 10 times quieter operation than
conventional instruments, enabling them to be located closer to the
point of care without noise disturbance. In addition, the new TSX
refrigerators and freezers use natural refrigerants, in accordance
with the U.S. Environmental Protection Agency (EPA) Significant New
Alternative Policy (SNAP) for improved laboratory sustainability.
-
The 16 x 500 mL capacity Thermo Scientific Sorvall BP 8 and 16
blood banking centrifuges are designed to maximize productivity
for blood processing centers by offering an increased capacity that
exceeds legacy systems by 33 percent, while maintaining previously
validated protocols. In a production environment where ease-of-use as
well as operator ergonomics are imperative, these centrifuges save
time and reduce physical strain with Auto-Door and Auto-Lid
technologies, enabling the opening and closing of the centrifuge door,
and removal and restacking of the windshielded rotor lid, to be a
seamless, hands-free operation. The Accumulated Centrifugal Effect
(ACE) function of the systems automatically adjusts run time to
account for and eliminate acceleration/deceleration variations that
could otherwise lead to the incomplete separation of platelets. The
centrifuges also feature the innovative Eco-Spin technology, which
uses windshielded rotors to allow energy savings of up to 64 percent.
All models are CE marked for the Medical Devices Directive 93/42/EEC
and are listed with the U.S. FDA. In addition, they conform to the
latest global safety standards, including UL listing.
-
Featuring a unique two-in-one hybrid rotor with interchangeable
fixed-angle and swinging buckets, the Thermo Scientific Medifuge
benchtop centrifuge provides application-specific flexibility.
Coupled with a compact footprint, it is an ideal choice for
laboratories with limited space. The centrifuge incorporates safety
and sustainability features such as an emergency lid-lock release,
quiet operation and a lightweight composite rotor that is easy to
handle and saves energy during acceleration/deceleration. The
centrifuge can accommodate a wide range of tubes, from 1.4 mL to 15
mL, and even 10 mL standard syringes, as well as enable fixed-angle
and swinging buckets to run at the same time for separation comparison
studies. The Medifuge centrifuge conforms to the latest clinical and
safety standards, such as UL, CE and IVD, and is listed with the U.S.
FDA as a Class 1 device.
More information can be found by visiting thermofisher.com/aabb.
About Thermo Fisher Scientific Thermo Fisher Scientific Inc.
is the world leader in serving science, with revenues of $17 billion and
more than 50,000 employees in 50 countries. Our mission is to enable our
customers to make the world healthier, cleaner and safer. We help our
customers accelerate life sciences research, solve complex analytical
challenges, improve patient diagnostics and increase laboratory
productivity. Through our premier brands - Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services - we
offer an unmatched combination of innovative technologies, purchasing
convenience and comprehensive support. For more information, please
visit www.thermofisher.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161022005003/en/
[ Back To TMCnet.com's Homepage ]
|